[Clinical application of a new nasolacrimal stent]

Hunan Yi Ke Da Xue Xue Bao. 2001 Jun 28;26(3):229-30.
[Article in Chinese]

Abstract

Seventy-two patients(ninety-one eyes) with epiphore due to obstruction of the nasolacrimal duct underwent nasolacrimal stent of our own disign. The period postoperative follow-up was 6 to 20(mean 14.5) months. Seventy-six eyes demonstrated obvious resolution of epiphore, twelve eyes had partial resolution, and three eyes had no resolution. The success rate were 96.7%. The common complications included occluded stent and a slightly blood-stanied nasal discharge. The placement of the nasolacrimal stent is a safe simple and effective method for treatment of epiphore due to obstruction of the nasolacrimal duct.

Publication types

  • English Abstract

MeSH terms

  • Adult
  • Dacryocystitis / therapy*
  • Female
  • Humans
  • Lacrimal Apparatus Diseases / therapy*
  • Lacrimal Duct Obstruction / therapy
  • Male
  • Middle Aged
  • Stents*